glp 1 agonists moa Frontiers Consensus Recommendations on GLP-1 RA
Description
Trial designs should integrate multidisciplinary oversight, including addiction specialists, ethicists, and patient advocates
The exposure groups were well balanced across all covariates, with no standardised difference above 0.02
Authors: Brianna M
Insulin resistance occurs when cells dont respond well to insulin
GLP-1 based therapies and disease course of inflammatory bowel disease
cis-acting DNA sequence controls glucagon gene expression in pancreatic islet cells
